Free

Prescription Drug User Fee Act 201 Partner Meeting

Event Information

Share this event

Date and Time

Location

Location

MedChi

1211 Cathedral St

Baltimore, MD 21201

View Map

Friends Who Are Going
Event description

Description

Please join us on Wednesday, April 5, 2017 for a partner meeting focusing on the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years 2018 through 2022.
Since 1992, PDUFA has provided faster access to over 1,500 new drugs and biologics, including treatments for cancer, cardiovascular disease, neurological diseases, infectious diseases and others. PDUFA has also helped improve America's competitiveness around the world. Since its passage, the U.S. has been the world leader not only in getting new medicines to market first but also in biotechnology research and development.

The goal of PDUFA is to supplement congressional appropriations so that the FDA can hire staff, improve systems, and establish a better managed human drug review process to make important therapies available to patients sooner without compromising the review quality or the FDA's high standards for safety, efficacy, and quality. By providing predictability in the review process, PDUFA can be an important tool in encouraging additional investment by biopharmaceutical companies. And added investment means more jobs. Biopharmaceutical companies in Maryland support nearly 26,000 jobs generating nearly $8 billion in wages. The current authorization of the program (PDUFA V) expires in September 2017. In these trying times, we must take advantage of any opportunity to not just guard those valuable jobs, but to create new ones.
Share with friends

Date and Time

Location

MedChi

1211 Cathedral St

Baltimore, MD 21201

View Map

Save This Event

Event Saved